These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2860220)

  • 1. The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice.
    Azmin MN; Florence AT; Handjani-Vila RM; Stuart JF; Vanlerberghe G; Whittaker JS
    J Pharm Pharmacol; 1985 Apr; 37(4):237-42. PubMed ID: 2860220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of niosomes and polysorbate 80 on the metabolism and excretion of methotrexate in the mouse.
    Azmin MN; Florence AT; Handjani-Vila RM; Stuart JF; Vanlerberghe G; Whittaker JS
    J Microencapsul; 1986; 3(2):95-100. PubMed ID: 3508183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of polysorbate 80 on the absorption and distribution of oral methotrexate (MTX) in mice.
    Azmin MN; Stuart JF; Calman KC; Florence AT
    Cancer Chemother Pharmacol; 1982; 9(3):161-4. PubMed ID: 7160051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution and elimination of methotrexate in mouse blood and brain after concurrent administration of polysorbate 80.
    Azmin MN; Stuart JF; Florence AT
    Cancer Chemother Pharmacol; 1985; 14(3):238-42. PubMed ID: 3995684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
    Abdelbary AA; AbouGhaly MH
    Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment.
    Srisuk P; Thongnopnua P; Raktanonchai U; Kanokpanont S
    Int J Pharm; 2012 May; 427(2):426-34. PubMed ID: 22310459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alkyl glucopyranoside-based niosomes containing methotrexate for pharmaceutical applications: evaluation of physico-chemical and biological properties.
    Muzzalupo R; Tavano L; La Mesa C
    Int J Pharm; 2013 Dec; 458(1):224-9. PubMed ID: 24060370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability.
    Zidan AS; Mokhtar Ibrahim M; Megrab NAE
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1450-1459. PubMed ID: 28420295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of niosomes containing rifampicin for lung targeting.
    Jain CP; Vyas SP
    J Microencapsul; 1995; 12(4):401-7. PubMed ID: 8583314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential distribution of liposome-entrapped [3H]methotrexate and labelled lipids after intravenous injection in a primate.
    Kimelberg HK
    Biochim Biophys Acta; 1976 Nov; 448(4):531-50. PubMed ID: 823974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged blood circulation of methotrexate by modulation of liposomal composition.
    Hong MS; Lim SJ; Lee MK; Kim YB; Kim CK
    Drug Deliv; 2001; 8(4):231-7. PubMed ID: 11757781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Permeation of Methotrexate via Loading into Ultra-permeable Niosomal Vesicles: Fabrication, Statistical Optimization, Ex Vivo Studies, and In Vivo Skin Deposition and Tolerability.
    Al-Mahallawi AM; Fares AR; Abd-Elsalam WH
    AAPS PharmSciTech; 2019 Apr; 20(5):171. PubMed ID: 31004239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate-bestatin interaction: involvement of P-glycoprotein and organic anion transporters in rats.
    Zhu Y; Meng Q; Wang C; Liu Q; Huo X; Zhang A; Sun P; Sun H; Li H; Liu K
    Int J Pharm; 2014 Apr; 465(1-2):368-77. PubMed ID: 24530518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of entrapment in liposomes on the in vivo distribution of [3H]methotrexate in a primate.
    Kimelberg HK; Tracy TF; Biddlecome SM; Bourke RS
    Cancer Res; 1976 Aug; 36(8):2949-57. PubMed ID: 819137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased intestinal absorption of methotrexate in the rat following repeated oral dosing.
    Sonneveld P; Storm AJ; Nooter K
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):133-6. PubMed ID: 3992025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The carrier potential of liposomes for methotrexate. Changing of the tissue levels of methotrexate in the organs of mice (author's transl)].
    Freise J; Schäfer G; Schmidt FW; Magerstedt P
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977 Nov; 90(2):187-95. PubMed ID: 145758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deformable liposomes for dermal administration of methotrexate.
    Trotta M; Peira E; Carlotti ME; Gallarate M
    Int J Pharm; 2004 Feb; 270(1-2):119-25. PubMed ID: 14726128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental study on targeted methotrexate delivery to the rabbit brain via magnetic resonance imaging-guided focused ultrasound.
    Mei J; Cheng Y; Song Y; Yang Y; Wang F; Liu Y; Wang Z
    J Ultrasound Med; 2009 Jul; 28(7):871-80. PubMed ID: 19546329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic study of niosome encapsulated insulin.
    Khaksa G; D'Souza R; Lewis S; Udupa N
    Indian J Exp Biol; 2000 Sep; 38(9):901-5. PubMed ID: 12561948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
    Kim CK; Han JH
    J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.